Sector: MedicalDyax Corp. (NASDAQ: DYAX)
Headlines
- DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
Nov 07, 2009 07:03 AM | DYAX
- Dyax Corp. to Host Third Quarter 2009 Earnings Call and Webcast
Oct 21, 2009 07:30 AM | DYAX
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Dyax Announces New Developments Related to Phage Display-Discovered Drug Candidates
Oct 13, 2009 07:33 AM | DYAX, SNY
- Dyax Corp. to Present at the JMP Securities Healthcare Focus Conference
Sep 25, 2009 07:30 AM | DYAX
- Reliability and Validity of Dyax's Novel Patient Reported Outcome Measures (PROs) Affirmed in Published Study
Sep 10, 2009 07:30 AM | DYAX
- Dyax Corp. to Present at Four Investor Conferences in September
Sep 03, 2009 07:30 AM | DYAX, UBS
- Dyax Announces Developments in Licensing and Funded Research Program
Aug 26, 2009 07:30 AM | AZN, DYAX, LLY
- Extreme FDA Calendar Trades: 20 Stocks Under $5
Jul 21, 2009 08:52 AM | ADLS, APPA, APPY, ARNA, COV, CRXX
- BioMedReports FDA Calendar: Seven Laggard Trades
Jun 17, 2009 04:34 PM | ABT, DYAX, ENDP, GTXI, LLY, OSIP
- Dyax Corp. Announces Third Quarter 2009 Financial Results
Oct 28, 2009 07:52 AM | CBST, DYAX
- Dyax Announces Completion of Common Stock Offering
Oct 05, 2009 04:53 PM | DYAX
- Dyax Announces Pricing of Public Offering of Common Stock
Sep 30, 2009 09:51 AM | DYAX
- Dyax Corp. Announces Expanded Roles for Two Senior Management Executives As Company Advances Commercialization Plan
Sep 01, 2009 12:57 PM | CBST, DYAX
- Dyax Corp. to Present at the Canaccord Adams Global Growth Conference
Aug 10, 2009 07:32 AM | DYAX
- James W. Fordyce Named to Ore Pharmaceuticals Board of Directors
Aug 03, 2009 05:52 PM | DYAX
- Dyax Corp. Announces Second Quarter 2009 Financial Results
Jul 22, 2009 07:54 AM | CBST, DYAX, SGMO
- Dyax Corp. to Host Second Quarter 2009 Earnings Call and Webcast
Jul 15, 2009 07:33 AM | DYAX
- Dyax Announces Underwriter's Exercise of Over-Allotment Option
Jun 30, 2009 07:51 AM | DYAX
- Dyax Announces Underwriter’s Exercise of Over-allotment Option
Jun 30, 2009 07:31 AM | DYAX
- Form 4 DYAX CORP For: Nov 13 Filed by: LEWIS HENRY R (10K)
Nov 17, 2009 09:32 AM
- Form 4 DYAX CORP For: Oct 01 Filed by: BLAIR HENRY E (10K)
Oct 05, 2009 06:01 PM
- Form 4 DYAX CORP For: Sep 15 Filed by: FORDYCE JAMES W (10K)
Sep 17, 2009 01:09 PM
- Form 4 DYAX CORP For: Aug 10 Filed by: MCLACHLAN DAVID J (10K)
Aug 11, 2009 05:54 PM
- Form 4 DYAX CORP For: Jun 15 Filed by: MIGAUSKY GEORGE V (10K)
Jun 16, 2009 10:19 AM
- Form 4 DYAX CORP For: Jun 04 Filed by: Christensen Gustav (10K)
Jun 05, 2009 01:23 PM
- Form 4 DYAX CORP For: Jun 01 Filed by: WOOD CLIVE (10K)
Jun 02, 2009 06:35 PM
- Form 4 DYAX CORP For: Apr 29 Filed by: WOOD CLIVE (10K)
Apr 30, 2009 08:49 PM
- Form 5 DYAX CORP For: Dec 31 Filed by: KEMPNER THOMAS L (10K)
Feb 12, 2009 05:32 PM
- Form 5 DYAX CORP For: Dec 31 Filed by: LEWIS HENRY R (10K)
Feb 12, 2009 05:28 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DYAX
|
Compare to S&P
|
| YTD |
7.42 %
|
-11.10 %
|
| 4 Weeks |
27.78 %
|
26.40 %
|
| 12 Weeks |
7.71 %
|
1.55 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 30.43 %
|
|
EPS Growth in Last Year: 44.83 %
|
|
Sales Growth in Last Quarter: 6.45 %
|
|
Sales Growth in Last Quarter: -17.89 %
|
|
